New Projects for Pistoia

Alongside updates on current projects, the audience heard three use-cases from organisations that have deployed Pistoia Alliance outputs to good effect. Daniel Baeschlin of Novartis presented their adoption of a CSCS solution, Stefan Klostermann of Roche discussed their use of HELM to develop a useful new antibody editor tool (itself now available freely under the same terms as HELM itself), and Misha Kapushesky discussed how he had used the concepts of an earlier project called Sequence Services to develop his company, GeneStack, into the success that it is today.

Read the full article here